[综合性治疗便失禁的医学:对东方和西方经验的思考]
1Department of Acupuncture and Traditional Chinese Medicine, Northwestern Health Science University, Minnesota 55431, USA.
概括
本文介绍了便失禁的综合医疗模式,强调以患者为中心的护理和多学科的方法. 它强调使用患者报告的结果和工具,如IMPACT尺度,以改善全球临床实践和研究.
科学领域:
- 胃肠病学和结肠直肠外科手术
- 综合医学是一个整体的医学.
- 医疗保健政策 医疗保健政策
背景情况:
- 便失禁 (FI) 是一个重要的全球健康问题.
- 现有的管理方法往往缺乏统一的,以患者为中心的框架.
- 多学科的共识和指导方针已经在过去的三十年里得到了发展.
研究的目的:
- 介绍一个新的综合医疗模型,用于便失禁.
- 概述这个以患者为中心的模型的概念框架和范围.
- 为制定共识指导方针提供信息,特别是针对中国的医疗保健环境.
主要方法:
- 30年来综合多学科共识和国际指导方针.
- 结合个人反思和临床经验.
- 审查以患者为中心的护理原则和患者报告的结果措施 (PROM).
- 评估多学科评估工具,例如IMPACT规模.
主要成果:
- 拟议的模型以患者为中心,赋予患者在治疗决策中的权力.
- 它整合了各种学科,并认识到PROMs的重要性.
- 像IMPACT等多学科工具可以提高临床标准.
- 包括针在内的国际见解为制定指南提供了途径.
结论:
- 综合医疗模式为便失禁管理提供了全面的方法.
- 以患者为中心和使用经过验证的工具对于改善护理至关重要.
- 适应国际最佳实践,如针,可以增强针对特定医疗保健系统的FI指南.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
148
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
148
Irritable Bowel Syndrome III: Medical and Nursing Management
210
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
210
Drugs for Treatment of Constipation-Predominant IBS
176
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
176
Drugs for Treatment of Diarrhea-Predominant IBS
179
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
179
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
Inflammatory Bowel Disease IV: Pharmacological Management
129
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
129


